FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Midei

Research Profile

Devices

Concepts & Ideas

Procedures

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Alexandra J Lansky; Vivian G Ng; Halil Mutlu; Ecaterina Cristea; Julian Benetato Guiran; Mark G Midei; William Newman; Mark Sanz; Poornima Sood; Julie Doostzadeh; Xiaolu Su; Roseann White; Sherry Cao; Krishnankutty Sudhir; Gregg W Stone
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Mark G Midei; Vicki J Coombs; David R Lowry; Michael N Drossner; Kerry C Prewitt; John C Wang; Michele B Loughrey; Sidney O Gottlieb
Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Midei (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
International journal of cardiology 2012;157(1):96-101.
2009: Alexandra J Lansky; Vivian G Ng; Halil Mutlu; Ecaterina Cristea; Julian Benetato Guiran; Mark G Midei; William Newman; Mark Sanz; Poornima Sood; Julie Doostzadeh; Xiaolu Su; Roseann White; Sherry Cao; Krishnankutty Sudhir; Gregg W Stone
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(5):719-27.
2007: Mark G Midei; Vicki J Coombs; David R Lowry; Michael N Drossner; Kerry C Prewitt; John C Wang; Michele B Loughrey; Sidney O Gottlieb
Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions.
Cardiology 2007;107(3):172-7.
2006: David E Kandzari; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; Charles O'Shaughnessy; Michael W Ball; Mark Turco; Robert J Applegate; Paul A Gurbel; Mark G Midei; Sejal S Badre; Laura Mauri; Kweli P Thompson; LeRoy A LeNarz; Richard E Kuntz
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
Journal of the American College of Cardiology 2006;48(12):2440-7.
2006: Victor L Serebruany; Mark G Midei; H Meilman; Alex I Malinin; David R Lowry
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
International journal of clinical practice 2006;60(7):863-6.
2006: Victor L Serebruany; Mark G Midei; H Meilman; Alex I Malinin; David R Lowry
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study.
Postgraduate medical journal 2006;82(968):404-10.
2005: Alexandra J Lansky; Ricardo A Costa; Michael Mooney; Mark G Midei; Henry K Lui; Warren Strickland; Roxana Mehran; Martin B Leon; Mary E Russell; Stephen G Ellis; Gregg W Stone
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
Journal of the American College of Cardiology 2005;45(8):1180-5.
2004: Victor L Serebruany; Mark G Midei; Alex I Malinin; Benjamin R Oshrine; David R Lowry; David C Sane; Jean-François Tanguay; Steven R Steinhubl; Peter B Berger; Christopher M O'Connor; Charles H Hennekens
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Archives of internal medicine 2004;164(18):2051-7.
2004: Alexandra J Lansky; Ricardo A Costa; Gary S Mintz; Yoshihiro Tsuchiya; Mark G Midei; David A Cox; Charles O'Shaughnessy; Robert A Applegate; Louis A Cannon; Michael Mooney; Anthony Farah; Mark A Tannenbaum; Steven Yakubov; Dean J Kereiakes; S Chiu Wong; Barry Kaplan; Ecaterina Cristea; Gregg W Stone; Martin B Leon; William D Knopf; William W O'Neill
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.
Circulation 2004;109(16):1948-54.
2004: David R Holmes; Martin B Leon; Jeffrey W Moses; Jeffrey J Popma; Donald E Cutlip; Peter J Fitzgerald; Charles Brown; Tim A Fischell; S Chiu Wong; Mark G Midei; David Snead; Richard E Kuntz
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Circulation 2004;109(5):634-40.
2003: Dean J Kereiakes; David A Cox; James Hermiller; Mark G Midei; William B Bachinsky; E Dean Nukta; Martin B Leon; Stanley Fink; Linda Marin; Alexandra J Lansky
Usefulness of a cobalt chromium coronary stent alloy.
The American journal of cardiology 2003;92(4):463-6.
2003: Gregg W Stone; Roxana Mehran; Mark G Midei; Ron Waksman; Gary L Schaer; Manuela Negoita; Alexandra J Lansky; Maurice Buchbinder
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts.
The American journal of cardiology 2003;92(3):312-4.
2003: Stephen L Kopecky; Ronnier J Aviles; Malcolm R Bell; Joseph K Lobl; Diane Tipping; Gregg Frommell; Karen Ramsey; Anne E Holland; Mark G Midei; Abnash Jain; Mirle Kellett; Raymond J Gibbons
A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
American heart journal 2003;146(1):146-52.
2003: Sorin J Brener; Mark G Midei; Dean Nukta; Dean J Kereiakes; David G Rizik; Donel Murphy; Danielle Brennan; David J Moliterno
A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial.
The Journal of invasive cardiology 2003;15(3):128-32.
2001: Dean J Kereiakes; Cindy L Grines; Edward T A Fry; P Esente; D Hoppensteadt; Mark G Midei; L Barr; W Matthai; M Todd; Thomas M Broderick; R Rubinstein; J Fareed; E Santoian; A Neiderman; Bruce R Brodie; James Zidar; James J Ferguson; Marc Cohen
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
The Journal of invasive cardiology 2001;13(4):272-8.
1999: Dean J Kereiakes; Mark G Midei; James Hermiller; Charles O'Shaughnessy; R Schlofmitz; Steven Yakubov; Stanley Fink; F Hu; N Nishimura; M Sievers; M E Valentine; Thomas M Broderick; Alexandra Lansky; Jeffrey Moses
Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment.
The American journal of cardiology 1999;84(12):1385-90.